Skip to main content
Clinical Trials/ISRCTN12035620
ISRCTN12035620
Completed
未知

Evaluating the effectiveness, and cost-effectiveness, of a pharmacist-led IT-based intervention (PINCER) when widely implemented in general practices to reduce the prevalence of patient exposure to hazardous prescribing, and the incidence of serious harm

niversity of Nottingham0 sites115 target enrollmentMarch 11, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Nottingham
Enrollment
115
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 11, 2021
End Date
April 30, 2021
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
niversity of Nottingham

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria for general practices:
  • 1\. Agree to take part and sign the organisation information document
  • 2\. Practices within the East Midlands who have taken part in the Health Foundation Scaling Up PINCER project
  • Inclusion criteria for patients:
  • 1\. All patients in the general practices taking part in the study

Exclusion Criteria

  • Exclusion criteria for general practices:
  • 1\. Practices who have not taken part in the Health Foundation Scaling Up PINCER project
  • Exclusion criteria for patients:
  • 2\. Patients with a computer code in their clinical records indicating that they do not wish for their medical records to be used for research or secondary purposes

Outcomes

Primary Outcomes

Not specified

Similar Trials